Related Posts

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder

Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.

Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information

This toolkit, comprised of fact sheets, worksheets, sample communications materials, and sample social media is designed to help aid how you support your own mental health journey, along with your community’s.

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.

St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections